Cerebral small-vessel disease and progression of brain atrophy The SMART-MR study

被引:81
|
作者
Kloppenborg, R. P. [1 ,4 ]
Nederkoorn, P. J. [4 ]
Grool, A. M. [1 ]
Vincken, K. L. [2 ]
Mali, W. P. T. M. [3 ]
Vermeulen, M. [4 ]
van der Graaf, Y. [1 ]
Geerlings, M. I. [1 ]
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands
关键词
WHITE-MATTER LESIONS; COGNITIVE DECLINE; HIPPOCAMPAL ATROPHY; RISK-FACTORS; FOLLOW-UP; RATES; LACUNES; VOLUMES; LADIS; AD;
D O I
10.1212/WNL.0b013e3182749f02
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To investigate whether severity and progression of periventricular and deep white matter lesions (WML) and lacunar infarcts were associated with progression of brain atrophy. Methods: Within the SMART-MR study, a prospective cohort on MRI changes in patients with symptomatic atherosclerotic disease, 565 patients (57 +/- 9 years) without large infarcts had vascular screening and 1.5 T MRI at baseline and after a mean follow-up of 3.9 years. With automated brain segmentation, total brain, cortical gray matter, ventricular, and WML volumes were estimated and expressed relative to intracranial volume (%). Lacunar infarcts were rated manually. Results: Using linear regression analyses adjusted for demographics and vascular risk factors, periventricular WML volume at baseline was associated with greater decrease in cortical gray matter volume (B = -1.73%, 95% confidence interval [CI] -3.15% to -0.30%, per 1% WML volume increase) and greater increase in ventricular volume (B = 0.12%, 95% CI 0.04% to 0.20%). Progression of periventricular WML volume corresponded with a greater decrease in cortical gray matter volume (B = -0.45%, 95% CI -0.9% to 0%) and greater increase in ventricular volume (B = 0.15%, 95% CI 0.1% to 0.2%). Presence of lacunar infarcts was associated with greater decline in total brain volume (B = -0.25%, 95% CI -0.49% to -0.01%) and progression of lacunar infarcts with a greater decrease of total brain (B = -0.30%, 95% CI -0.59% to 0.01%) and cortical gray matter volume (B = -0.81%, 95% CI -1.43% to -0.20%). Conclusions: In patients with symptomatic atherosclerotic disease, presence and progression of periventricular WML and lacunar infarcts is associated with greater progression of brain atrophy independent of vascular risk factors. Neurology (R) 2012; 79: 2029-2036
引用
收藏
页码:2029 / 2036
页数:8
相关论文
共 50 条
  • [31] Brain Atrophy and Cerebral Small Vessel Disease A Prospective Follow-Up Study
    Nitkunan, Arani
    Lanfranconi, Silvia
    Charlton, Rebecca A.
    Barrick, Thomas R.
    Markus, Hugh S.
    STROKE, 2011, 42 (01) : 133 - 138
  • [32] Brain atrophy accelerates cognitive decline in cerebral small vessel disease The LADIS study
    Jokinen, H.
    Lipsanen, J.
    Schmidt, R.
    Fazekas, F.
    Gouw, A. A.
    van der Flier, W. M.
    Barkhof, F.
    Madureira, S.
    Verdelho, A.
    Ferro, J. M.
    Wallin, A.
    Pantoni, L.
    Inzitari, D.
    Erkinjuntti, T.
    NEUROLOGY, 2012, 78 (22) : 1785 - 1792
  • [33] Cerebral Small-Vessel Disease in Neuro-Behcet Disease
    Yoshimura, Sohei
    Ago, Tetsuro
    Koga, Masatoshi
    Kamouchi, Masahiro
    Kitazono, Takanari
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (08): : E237 - E239
  • [34] Biomarkers involved in the pathogenesis of cerebral small-vessel disease
    Liu, Xiaolu
    Sun, Pei
    Yang, Jing
    Fan, Yuhua
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [35] White Matter Lesions and Lacunar Infarcts Are Independently and Differently Associated with Brain Atrophy: The SMART-MR Study
    Appelman, Auke P. A.
    Vincken, Koen L.
    van der Graaf, Yolanda
    Vlek, Anne L. M.
    Witkamp, Theo D.
    Mali, Willem P. T. M.
    Geerlings, Mirjam I.
    CEREBROVASCULAR DISEASES, 2010, 29 (01) : 28 - 35
  • [36] Fiber Connectivity Density in Cerebral Small-Vessel Disease Patients With Mild Cognitive Impairment and Cerebral Small-Vessel Disease Patients With Normal Cognition
    Liu, Chengxia
    Shi, Lin
    Zhu, Wenhao
    Yang, Shiqi
    Sun, Pan
    Qin, Yuanyuan
    Tang, Xiangyu
    Zhang, Shun
    Yao, Yihao
    Wang, Zhenxiong
    Zhu, Wenzhen
    Wang, Defeng
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [37] Cerebral Small Vessel Disease and Risk of Death, Ischemic Stroke, and Cardiac Complications in Patients With Atherosclerotic Disease The Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) Study
    Conijn, Mandy M. A.
    Kloppenborg, Raoul P.
    Algra, Ale
    Mali, Willem P. Th. M.
    Kappelle, L. Jaap
    Vincken, Koen L.
    van der Graaf, Yolanda
    Geerlings, Mirjam I.
    STROKE, 2011, 42 (11) : 3105 - U290
  • [38] Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study
    Luo, Xiao
    Jiaerken, Yerfan
    Yu, Xinfeng
    Huang, Peiyu
    Qiu, Tiantian
    Jia, Yunlu
    Li, Kaicheng
    Xu, Xiaojun
    Shen, Zhujing
    Guan, Xiaojun
    Zhou, Jiong
    Zhang, Minming
    ONCOTARGET, 2017, 8 (27) : 44477 - 44489
  • [39] Hypertension and longitudinal changes in cerebral blood flow: The SMART-MR study
    Muller, Majon
    van der Graaf, Yolanda
    Visseren, Frank L.
    Mali, Willem P. Th M.
    Geerlings, Mirjam I.
    ANNALS OF NEUROLOGY, 2012, 71 (06) : 825 - 833
  • [40] CEREBRAL SMALL-VESSEL DISEASE IN THE PROGNOSIS OF ACUTE CEREBRAL HEMORRHAGE IN NORTHEASTERN CHINA: A RETROSPECTIVE STUDY
    Tian, J. N.
    Yang, C. X.
    Liang, S. L.
    Wang, S.
    Shi, X. D.
    Wang, X. K.
    Zhu, Y. L.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (04): : 1249 - 1254